Kiri H Beilby, Ezra Kneebone, Tessa J Roseboom, Indah M van Marrewijk, Jeremy G Thompson, Robert J Norman, Rebecca L Robker, Ben Willem J Mol, Rui Wang
{"title":"Offspring physiology following the use of IVM, IVF and ICSI: a systematic review and meta-analysis of animal studies.","authors":"Kiri H Beilby, Ezra Kneebone, Tessa J Roseboom, Indah M van Marrewijk, Jeremy G Thompson, Robert J Norman, Rebecca L Robker, Ben Willem J Mol, Rui Wang","doi":"10.1093/humupd/dmac043","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Since the birth of the first baby using IVF technology in 1978, over 10 million children have been conceived via ART. Although most aspects of ARTs were developed in animal models, the introduction of these technologies into clinical practice was performed without comprehensive assessment of their long-term safety. The monitoring of these technologies over time has revealed differences in the physiology of babies produced using ARTs, yet due to the pathology of those presenting for treatment, it is challenging to separate the cause of infertility from the effect of treatments offered. The use of systematic review and meta-analysis to investigate the impacts of the predominant ART interventions used clinically in human populations on animals produced in healthy fertile populations offers an alternative approach to understanding the long-term safety of reproductive technologies.</p><p><strong>Objective and rationale: </strong>This systematic review and meta-analysis aimed to examine the evidence available from animal studies on physiological outcomes in the offspring conceived after IVF, IVM or ICSI, compared to in vivo fertilization, and to provide an overview on the landscape of research in this area.</p><p><strong>Search methods: </strong>PubMed, Embase and Commonwealth Agricultural Bureaux (CAB) Abstracts were searched for relevant studies published until 27 August 2021. Search terms relating to assisted reproductive technology, postnatal outcomes and mammalian animal models were used. Studies that compared postnatal outcomes between in vitro-conceived (IVF, ICSI or IVM) and in vivo-conceived mammalian animal models were included. In vivo conception included mating, artificial insemination, or either of these followed by embryo transfer to a recipient animal with or without in vitro culture. Outcomes included birth weight, gestation length, cardiovascular, metabolic and behavioural characteristics and lifespan.</p><p><strong>Outcomes: </strong>A total of 61 studies in five different species (bovine, equine, murine, ovine and non-human primate) met the inclusion criteria. The bovine model was the most frequently used in IVM studies (32/40), while the murine model was mostly used in IVF (17/20) and ICSI (6/8) investigations. Despite considerable heterogeneity, these studies suggest that the use of IVF or maturation results in offspring with higher birthweights and a longer length of gestation, with most of this evidence coming from studies in cattle. These techniques may also impair glucose and lipid metabolism in male mice. The findings on cardiovascular outcomes and behaviour outcomes were inconsistent across studies.</p><p><strong>Wider implications: </strong>Conception via in vitro or in vivo means appears to have an influence on measurable outcomes of offspring physiology, manifesting differently across the species studied. Importantly, it can be noted that these measurable differences are noticeable in healthy, fertile animal populations. Thus, common ART interventions may have long-term consequences for those conceived through these techniques, regardless of the pathology underpinning diagnosed infertility. However, due to heterogeneous methods, results and measured outcomes, highlighted in this review, it is difficult to draw firm conclusions. Optimizing animal and human studies that investigate the safety of new reproductive technologies will provide insight into safeguarding the introduction of novel interventions into the clinical setting. Cautiously prescribing the use of ARTs clinically may also be considered to reduce the chance of promoting adverse outcomes in children conceived before long-term safety is confidently documented.</p>","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":"29 3","pages":"272-290"},"PeriodicalIF":14.8000,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/62/d5/dmac043.PMC10152177.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Reproduction Update","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/humupd/dmac043","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 5
Abstract
Background: Since the birth of the first baby using IVF technology in 1978, over 10 million children have been conceived via ART. Although most aspects of ARTs were developed in animal models, the introduction of these technologies into clinical practice was performed without comprehensive assessment of their long-term safety. The monitoring of these technologies over time has revealed differences in the physiology of babies produced using ARTs, yet due to the pathology of those presenting for treatment, it is challenging to separate the cause of infertility from the effect of treatments offered. The use of systematic review and meta-analysis to investigate the impacts of the predominant ART interventions used clinically in human populations on animals produced in healthy fertile populations offers an alternative approach to understanding the long-term safety of reproductive technologies.
Objective and rationale: This systematic review and meta-analysis aimed to examine the evidence available from animal studies on physiological outcomes in the offspring conceived after IVF, IVM or ICSI, compared to in vivo fertilization, and to provide an overview on the landscape of research in this area.
Search methods: PubMed, Embase and Commonwealth Agricultural Bureaux (CAB) Abstracts were searched for relevant studies published until 27 August 2021. Search terms relating to assisted reproductive technology, postnatal outcomes and mammalian animal models were used. Studies that compared postnatal outcomes between in vitro-conceived (IVF, ICSI or IVM) and in vivo-conceived mammalian animal models were included. In vivo conception included mating, artificial insemination, or either of these followed by embryo transfer to a recipient animal with or without in vitro culture. Outcomes included birth weight, gestation length, cardiovascular, metabolic and behavioural characteristics and lifespan.
Outcomes: A total of 61 studies in five different species (bovine, equine, murine, ovine and non-human primate) met the inclusion criteria. The bovine model was the most frequently used in IVM studies (32/40), while the murine model was mostly used in IVF (17/20) and ICSI (6/8) investigations. Despite considerable heterogeneity, these studies suggest that the use of IVF or maturation results in offspring with higher birthweights and a longer length of gestation, with most of this evidence coming from studies in cattle. These techniques may also impair glucose and lipid metabolism in male mice. The findings on cardiovascular outcomes and behaviour outcomes were inconsistent across studies.
Wider implications: Conception via in vitro or in vivo means appears to have an influence on measurable outcomes of offspring physiology, manifesting differently across the species studied. Importantly, it can be noted that these measurable differences are noticeable in healthy, fertile animal populations. Thus, common ART interventions may have long-term consequences for those conceived through these techniques, regardless of the pathology underpinning diagnosed infertility. However, due to heterogeneous methods, results and measured outcomes, highlighted in this review, it is difficult to draw firm conclusions. Optimizing animal and human studies that investigate the safety of new reproductive technologies will provide insight into safeguarding the introduction of novel interventions into the clinical setting. Cautiously prescribing the use of ARTs clinically may also be considered to reduce the chance of promoting adverse outcomes in children conceived before long-term safety is confidently documented.
背景:自1978年第一个使用体外受精技术的婴儿出生以来,已有超过1000万儿童通过ART受孕。尽管art的大多数方面是在动物模型中开发的,但将这些技术引入临床实践时并未对其长期安全性进行全面评估。随着时间的推移,对这些技术的监测揭示了使用抗逆转录病毒疗法产生的婴儿在生理上的差异,但由于那些前来治疗的人的病理,将不育的原因与所提供治疗的效果分开是具有挑战性的。通过系统回顾和荟萃分析来调查临床人群中使用的主要抗逆转录病毒治疗干预措施对健康可育人群中生产的动物的影响,为了解生殖技术的长期安全性提供了另一种方法。目的和基本原理:本系统综述和荟萃分析旨在研究体外受精、体外受精或ICSI受孕后后代生理结果与体内受精相比的动物研究证据,并概述该领域的研究前景。检索方法:检索PubMed、Embase和Commonwealth Agricultural bureau (CAB)摘要,检索截至2021年8月27日发表的相关研究。使用了与辅助生殖技术、产后结果和哺乳动物模型相关的搜索词。比较体外受孕(IVF, ICSI或IVM)和体内受孕哺乳动物模型的产后结局的研究包括在内。体内受孕包括交配,人工授精,或其中任何一种,然后将胚胎移植到有或没有体外培养的受体动物。结果包括出生体重、妊娠期长短、心血管、代谢和行为特征以及寿命。结果:5种不同物种(牛、马、鼠、羊和非人灵长类动物)共61项研究符合纳入标准。牛模型是IVM研究中最常用的模型(32/40),而小鼠模型主要用于IVF(17/20)和ICSI(6/8)研究。尽管存在相当大的异质性,但这些研究表明,使用体外受精或成熟会导致后代的出生体重更高,妊娠期更长,这些证据大多来自对牛的研究。这些技术也可能损害雄性小鼠的葡萄糖和脂质代谢。研究中关于心血管结局和行为结局的发现不一致。更广泛的影响:通过体外或体内方式受孕似乎对后代生理的可测量结果有影响,在研究的物种中表现不同。重要的是,可以注意到,这些可测量的差异在健康的、可生育的动物种群中是明显的。因此,无论诊断为不孕症的病理基础如何,普通的ART干预措施可能对通过这些技术受孕的人产生长期影响。然而,由于本综述中强调的方法、结果和测量结果的异质性,很难得出确定的结论。优化研究新生殖技术安全性的动物和人类研究,将为保护新干预措施进入临床环境提供见解。也可以考虑谨慎地在临床上使用抗逆转录病毒药物,以减少在长期安全性得到充分证明之前受孕的儿童出现不良后果的机会。
期刊介绍:
Human Reproduction Update is the leading journal in its field, boasting a Journal Impact FactorTM of 13.3 and ranked first in Obstetrics & Gynecology and Reproductive Biology (Source: Journal Citation ReportsTM from Clarivate, 2023). It specializes in publishing comprehensive and systematic review articles covering various aspects of human reproductive physiology and medicine.
The journal prioritizes basic, transitional, and clinical topics related to reproduction, encompassing areas such as andrology, embryology, infertility, gynaecology, pregnancy, reproductive endocrinology, reproductive epidemiology, reproductive genetics, reproductive immunology, and reproductive oncology. Human Reproduction Update is published on behalf of the European Society of Human Reproduction and Embryology (ESHRE), maintaining the highest scientific and editorial standards.